We are live on ! Find out more
AP

Appleton Partners Portfolio holdings

AUM $1.63B
1-Year Est. Return 38.57%
This Fund
S&P 500
This Quarter Est. Return
+0.6%
1 Year Est. Return
+38.57%
3 Year Est. Return
+101.09%
5 Year Est. Return
+116.43%
10 Year Est. Return
+424.6%
AUM
$489M
AUM Growth
-$16.7M
Cap. Flow
-$15M
Cap. Flow %
-3.06%
Top 10 Hldgs %
23.12%
Holding
214
New
8
Increased
52
Reduced
123
Closed
10

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$3.94M
2
AGN
Allergan plc
AGN
+$3.03M
3
AMZN icon
Amazon
AMZN
+$2.76M
4
AVGO icon
Broadcom
AVGO
+$1.42M
5
DLTR icon
Dollar Tree
DLTR
+$1.18M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$4.25M
2
C icon
Citigroup
C
+$3.43M
3
UAA icon
Under Armour
UAA
+$1.92M
4
GILD icon
Gilead Sciences
GILD
+$1.44M
5
ROP icon
Roper Technologies
ROP
+$1.33M

Sector Composition

Rank Sector Weight
1 Healthcare 17.15%
2 Financials 15.07%
3 Technology 13.59%
4 Consumer Discretionary 11.59%
5 Consumer Staples 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAS icon
26
Hasbro
HAS
$12.4B
$6.43M 1.31%
76,505
+2,195
+3% +$186K
SHW icon
27
Sherwin-Williams
SHW
$76.6B
$6.4M 1.31%
65,391
+2,418
+4% +$236K
ABBV icon
28
AbbVie
ABBV
$454B
$6.23M 1.27%
100,687
-3,503
-3% -$213K
WAB icon
29
Wabtec
WAB
$50.3B
$6.15M 1.26%
87,623
-4,076
-4% -$317K
GS icon
30
Goldman Sachs
GS
$317B
$5.93M 1.21%
39,896
-1,382
-3% -$216K
GILD icon
31
Gilead Sciences
GILD
$162B
$5.61M 1.15%
67,236
-16,178
-19% -$1.44M
IBB icon
32
iShares Biotechnology ETF
IBB
$9.35B
$5.49M 1.12%
63,960
-14,124
-18% -$1.27M
SLB icon
33
SLB Ltd
SLB
$70.6B
$5.19M 1.06%
65,672
-3,812
-5% -$292K
ICE icon
34
Intercontinental Exchange
ICE
$81B
$5.13M 1.05%
100,260
+5,110
+5% +$258K
KHC icon
35
Kraft Heinz
KHC
$30.1B
$4.97M 1.02%
56,217
-1,059
-2% -$87.1K
ZTS icon
36
Zoetis
ZTS
$31.3B
$4.95M 1.01%
104,235
-3,781
-4% -$179K
AKAM icon
37
Akamai
AKAM
$17.1B
$4.84M 0.99%
86,593
-13,540
-14% -$712K
ROP icon
38
Roper Technologies
ROP
$35.1B
$4.8M 0.98%
28,164
-7,605
-21% -$1.33M
MSFT icon
39
Microsoft
MSFT
$2.83T
$4.64M 0.95%
90,754
+237
+0.3% +$12.3K
NXPI icon
40
NXP Semiconductors
NXPI
$70B
$4.41M 0.9%
56,350
+2,102
+4% +$180K
UNH icon
41
UnitedHealth
UNH
$385B
$4.17M 0.85%
+29,523
New +$3.94M
MDLZ icon
42
Mondelez International
MDLZ
$77.1B
$3.92M 0.8%
86,070
-3,946
-4% -$172K
MCD icon
43
McDonald's
MCD
$187B
$3.87M 0.79%
32,176
-1,045
-3% -$131K
CCL icon
44
Carnival Corporation Ltd
CCL
$34.6B
$3.73M 0.76%
84,305
-845
-1% -$41.4K
ACN icon
45
Accenture
ACN
$84.9B
$3.59M 0.73%
31,689
+718
+2% +$83.3K
FHI icon
46
Federated Hermes
FHI
$4.35B
$3.55M 0.73%
123,240
-10,090
-8% -$309K
AMZN icon
47
Amazon
AMZN
$2.51T
$3.43M 0.7%
95,980
+81,520
+564% +$2.76M
CERN
48
DELISTED
Cerner Corp
CERN
$3.42M 0.7%
58,281
-3,281
-5% -$183K
VRSN icon
49
VeriSign
VRSN
$23.8B
$3.33M 0.68%
38,507
-1,970
-5% -$170K
GOOG icon
50
Alphabet (Google) Class C
GOOG
$3.89T
$3.27M 0.67%
94,400
-6,120
-6% -$220K

Similar funds

Appleton Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Appleton Partners held 214 positions worth $489M, down 3.3% from $506M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Appleton Partners withdrew a net $15M in Q2 2016, closing 10 positions and reducing 123 holdings. Its most notable exit was Perrigo, an estimated $412K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Appleton Partners opened a new position in UnitedHealth worth $4.17M.

  • Appleton Partners's largest Q2 2016 buy was UnitedHealth: 29,523 shares worth $4.17M.
  • Appleton Partners added most to Allergan plc in Q2 2016, an estimated $3.03M increase.
  • Appleton Partners's biggest Q2 2016 reduction was Aptiv, cutting an estimated $4.25M.
  • Appleton Partners fully exited Perrigo in Q2 2016, selling an estimated $412K.
  • Appleton Partners's ten largest holdings make up 23% of its $489M portfolio in Q2 2016.
  • Appleton Partners opened 8 new positions and closed 10 in Q2 2016.
  • Appleton Partners's portfolio value fell 3.3% quarter-over-quarter to $489M.

Based on Appleton Partners's 13F filing for Q2 2016, filed 3 Aug 2016.